ZOSTAVAX: Approval, Efficacy, and Cost in Taiwan - Pharmacology

More Info

---

ZOSTAVAX is a vaccine designed to reduce the risk of developing shingles (herpes zoster) in older adults. It is particularly important for individuals aged 60 and above, as the incidence of shingles increases with age. Here’s a comprehensive overview based on your questions regarding its approval, efficacy, and cost in Taiwan.

1. Approval and Efficacy: ZOSTAVAX has been approved for use in Taiwan and is available for self-administration. The vaccine is effective in reducing the incidence of shingles by approximately 50% in individuals aged 60 and older. The efficacy is highest in the 60-69 age group, where it can reduce the risk by up to 64%. It is important to note that ZOSTAVAX is a live attenuated vaccine, meaning it contains a weakened form of the varicella-zoster virus, which is the virus that causes shingles. Due to its live nature, certain populations should avoid this vaccine, including individuals with compromised immune systems (such as those undergoing chemotherapy, those with untreated HIV, or those on immunosuppressive medications), pregnant women, and individuals with certain types of cancer.

2. Duration of Protection: The protection offered by ZOSTAVAX is generally considered to last for about three years. After this period, the effectiveness may diminish, and a booster dose may be recommended, although this is subject to ongoing research and guidelines from health authorities.

3. Cost: In Taiwan, the self-paid cost for ZOSTAVAX is approximately NT$6,000. This price may vary slightly depending on the healthcare facility or clinic where the vaccine is administered. It is advisable for individuals to check with local hospitals or clinics for the most accurate pricing and availability.

In summary, ZOSTAVAX is an important vaccine for older adults to help prevent shingles, with a significant reduction in incidence and a reasonable cost for self-administration. It is crucial for individuals considering this vaccine to consult with their healthcare provider to ensure it is appropriate for their health status and to discuss any potential risks, especially if they have underlying health conditions. Additionally, keeping abreast of any new guidelines or recommendations regarding shingles vaccination is beneficial, as the medical community continues to evolve its understanding of vaccine efficacy and safety.